Sign in
4

Changes in Ownership

Oruka Therapeutics, Inc. Filed Acc 0001181431-11-032441

Options or other derivatives

  • President and CEO acquired 30,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

BRISTOW MICHAEL R · President and CEO

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2011-05-20 Grant or award : show line 1 in the form Option to Purchase Common Stock −30,000 $2.24 2021-05-20 30,000 30,000 D
Loading xslF345X03/rrd313037.xml…